Infection and Immunity, December 2001, p. 7858-7865, Vol. 69, No. 12
0019-9567/01/$04.00+0 DOI: 10.1128/IAI.69.12.7858-7865.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
B Activity in Staphylococcus
aureus Is Controlled by RsbU and an Additional Factor(s) during
Bacterial Growth
Department of Microbiology, Dartmouth Medical School, Hanover, New Hampshire 03755,1 and Department of Immunology, Microbiology, Pathology, and Infectious Diseases, Karolinska Institutet, Huddinge University Hospital, S-141 86 Huddinge, Sweden2
Received 12 July 2001/Returned for modification 13 August 2001/Accepted 5 September 2001
| |
ABSTRACT |
|---|
|
|
|---|
Two genes of the sigB operon,
rsbU and rsbV, were deleted in an
rsbU+ strain (FDA486) to evaluate the
contribution of these two genes to
B activity in
Staphylococcus aureus. The
B protein
level and the transcription of two
B-dependent promoters
(sigB and sarA P3 transcripts)
were analyzed in the constructed mutants. A deletion of the first gene
(rsbU) within the sigB operon led only to
a partial reduction in 
activity. A deletion of the
second gene (rsbV) resulted in a more dramatic reduction
in the
B protein level and its activity than did the
deletion of rsbU, thus indicating that RsbV can be
activated independent of RsbU. In the parental strain, the
B-dependent transcript initiated upstream of
rsbV was 28-fold higher than the
A-dependent transcript originating from the
rsbU promoter. The level of the
B-dependent transcript decreased up to 50% in the
rsbU mutant and up to 90% in the rsbV
mutant compared with the transcript in the wild type. The yellow
pigment of S. aureus colonies, a
B-dependent phenotype, was partially reduced in the
rsbU and rsbV mutants, whereas
alpha-hemolysin was increased. Additionally, the sarA P3
promoter activity of the parental strain was induced to a higher level
in response to pH 5.5 than was that of the rsbU or
rsbV mutant, indicating that RsbU is the major activator
of the
B response to acid stress. Using a
tetracycline-inducible system to modulate the expression of RsbW, we
progressively repressed pigment production, presumably by reducing the
free
B level. Collectively, our data indicated that RsbU
and RsbV in S. aureus contributed to
different levels of
B protein expression and varying
B activities. Although RsbV can activate
B independent of RsbU, RsbU remains the major activator
of
B during acid stress.
| |
INTRODUCTION |
|---|
|
|
|---|
Staphylococcus aureus is
one of the most common etiological agents of wound infections, which
can lead to severe infections such as septicemia, osteomyelitis, or
endocarditis. Eradication of the organism is extremely difficult,
particularly in hospitals, due to its ability to survive in extreme
conditions, both in the host and in the environment. This flexibility
of S. aureus survival in response to diverse
environmental cues is often attributable to global regulatory elements
(e.g., sarA and agr). In some cases, an
alternative sigma factor such as
B, by virtue
of its regulatory effect on target promoters (e.g., the P3 promoter of
sarA), may also play a role.
In contrast to the primary sigma factor (
A)
required for the transcription of housekeeping genes, SigB is one of
the alternative sigma factors (17, 19, 24, 25) that have
been shown to respond to environmental stresses (15, 40),
probably executing bacterial adaptive responses essential for
pathogenesis and survival. Although considerable information on
B regulation in Bacillus subtilis
exists (1, 3, 4, 14, 18, 20, 33, 34, 35, 36, 37, 38, 39,
43), little is known about how
B
activity (i.e., free
B) is controlled in
S. aureus.
The regulation of
B activity in B. subtilis is complex, requiring a cascade of events to yield
the free and active forms of the
B protein.
Under normal conditions, when
B is inactive,
the
B protein is bound tightly to the anti-
factor, RsbW (4, 13, 27). RsbV, in its dephosphorylated
form, can bind competitively to RsbW, resulting in the release of
B to bind to its target promoters to initiate
transcription. The binding of RsbW to
B or to
RsbV is dependent on the phosphorylation status of RsbV, normally
modulated by the phosphatase RsbU or RsbP (36, 37, 43). In
B. subtilis, the RsbR-S-T gene complex represents
an environmental sensing module which requires a GTP binding protein (Obg) (33, 34, 41) and a 50S ribosome subunit protein
(L13) for stress activation (34), eventually leading to
RsbU activation (i.e., becoming a phosphatase). Curiously, the RsbR-S-T
sensor module is absent in S. aureus.
Several studies have reported the phenotypic role of
B in S. aureus strains,
including COL, a methicillin-resistant S. aureus strain, MA12.2, RN6390, and 8325-4. RN6390 and 8325-4 are natural rsbU deletion mutants. Phenotypic changes in these strains
with a sigB mutation include increased production of
alpha-hemolysin in strains RN6390 and COL (8), reduction
of yellow pigmentation in strains COL and Newman (21),
restoration of methicillin sensitivity in methicillin-resistant
S. aureus strain COL (44), and
decreased ability to form biofilm in strain MA12.2 (32).
Although
B may be related to bacterial
survival during stress (22), the sigB mutant
did not differ significantly in pathogenicity from the parental strains
(RN6390, 8325-4, and WCUH29) in several acute animal infection models
(7, 28). However, the contributions of
B to chronic infections and persistence inside
host cells are not known.
The sarA locus is composed of three overlapping transcripts
designated sarA P1, sarA P3, and sarA
P2 initiated from the P1, P3, and P2 promoters, respectively. Due to
the overlapping nature of these three transcripts, all of them encode
the 372-bp sarA open reading frame. Based on Northern and in
vitro transcription assay analyses, the sarA P3 promoter is
a
B-dependent promoter (12, 26,
27). Since
B partially controls the
expression of SarA, the sarA regulatory molecule, by
modulating the P3 promoter activity, it was hypothesized that
B could be indirectly involved in the
regulation of virulence genes such as alpha-toxin (8, 21).
In this study, we scrutinized the effects of RsbU, RsbV, and RsbW on
the level and activity of the
B protein,
examining in particular the sarA P3 promoter. We present evidence that an additional factor other than RsbU is required for full
B activity in S. aureus.
| |
MATERIALS AND METHODS |
|---|
|
|
|---|
Bacterial strains.
The bacterial strains and plasmids used
in this study are listed in Table 1.
FDA486 is an S. aureus strain previously used to
study fibrinogen binding proteins (6, 31). RN6390 is a standard laboratory S. aureus strain with a
genetic background similar to that of strain 8325-4. 8325-4 and its
derivatives contain an 11-bp deletion in the rsbU gene
(21) but still express
B, albeit
at a lower level (8). RN4220 is a restriction-deficient S. aureus host strain used as the initial
recipient for transformation of plasmids (30).
Escherichia coli XL1-Blue was used for cloning isolated DNA
fragments.
|
Sequence analysis of rsbU in FDA486.
Staphylococcal chromosomal DNA was isolated by using the Qiagen genomic
DNA kit (Qiagen, Valencia, Calif.). The rsbU gene was
amplified from the DNA of FDA486 using primers rsbU-1
(5'-GCCGGAATTCGTGGAAGAATTTAAGCAACA-3') and rsbU-2
(5'-TTCCCTCGAGATTTACTCTTTTTATAATCA-3'). The PCR fragment was
purified with a QIAquick nucleotide removal kit (Qiagen) and subsequently sequenced with oligonucleotides rsbU-1 and U-rsbV-1 (5'-GCATGCGAATTCAACGAAACATATTTATCT-3'). Sequence data of the
PCR fragment revealed an intact rsbU gene in FDA486,
indicating that this S. aureus strain was
suitable for our
B studies.
Construction of plasmids p
rsbU and
p
rsbV and inactivation of rsbU and
rsbV in FDA486 and RN6390.
Regions flanking
rsbU and rsbV were amplified with 5' overhang
restriction sites (EcoRI and SmaI, underlined)
using primers U-rsbU-1
(5'-GCATGCGAATTCAACGAAACATATTTATCT-3') and
U-rsbU-2 (5'-AGTTGCCCCGGGACTTCCTTACA-3') for rsbU and primers U-rsbV-1
(5'-AATGGAATTCCTTTCAGTGGCGGCACAA-3') and
U-rsbV-2 (5'-TTCCCCCGGGACTTATTAAAAATATC-3') for
rsbV. The fragments were digested with EcoRI and
SmaI and cloned separately into the temperature-sensitive
shuttle vector pCL52.2 (23). pCL52.2 has a
temperature-sensitive origin of replication that is active in
S. aureus at 32°C but not at 42°C. Downstream
regions of rsbU and rsbV were amplified with
flanking PstI and HindIII restriction sites
(underlined) with primers D-rsbU-1
(5'-CCCAACTGCAGAAGATGATATGACTATTTTG-3') and
D-rsbU-2 (5'-TCGCCAAGCTTTAAACCTAGGCCACCTTC-3')
for rsbU and primers D-rsbV-1
(5'-AAAACTGCAGCGGAGGTCGAATAACATG-3') and
D-rsbV-2 (5'-GTGCAAGCTTTAATTCAGCGGTTAGTTC-3')
for rsbV. The downstream fragments were digested with
PstI and HindIII and cloned separately into
the PstI-HindIII sites of pCL52.2 already
containing the upstream fragments. The ermC gene was
amplified by two primers (5'-ATCCCTCAGGCTTTGGCTAACACACACGC-3'
and 5'-TGACCTGAATAAGGAAACAAGTTAAGGGATGCAG-3'). The PCR
fragment encoding the ermC gene was cloned into pCR2.1 (Invitrogen, Carlsbad, Calif.) and subcloned into pBluescript as an
EcoRI-HindIII fragment, resulting in plasmid
pAL552. The ermC gene was excised from pALC552 by
BamHI-SalI digestion and introduced into the
BamHI-SalI site of pCL52.2 between the two previously cloned fragments. The resulting plasmids were designated p
rsbU and p
rsbV.
rsbU and p
rsbV, initially isolated from
E. coli, were introduced into S. aureus RN4220 by electroporation followed by transduction into strains FDA486 and RN6390 with phage
11. Transductants were selected on tryptic soy agar plates containing tetracycline (3 µg
ml
1) at 32°C. Transductants with
p
rsbU or p
rsbV were grown separately in
O3GL broth (29, 30) with tetracycline (3 µg
ml
1) and erythromycin (5 µg
ml
1) at 32°C overnight following 12 h of
growth in media with erythromycin at 42°C. The cultures were diluted
1:100 in fresh O3GL broth and incubated at 32°C without antibiotics
for 12 h; this step was repeated several times to yield
erythromycin-resistant but tetracycline-sensitive colonies, implying
plasmid loss and subsequent homologous recombination at the sequences
flanking rsbU or rsbV. The deletion included the
respective ribosomal binding sites of rsbU and
rsbV.
The deletions of rsbU and rsbV were confirmed by
PCR, sequencing, and Southern hybridization. We used a primer
(5'-ATGGTCTATTTCAATGGCAGTTAC-3') corresponding to bases 331 to 335 of the ermC gene (FASTA GenBank accession no. Y17294)
in combination with a primer within the sigB gene
(5'-TGCCAAGCTTTGTAATTTCTTAATTGCC-3') to confirm the rsbU deletion or in combination with a primer downstream of
the sigB operon (5'-AATATCCTTCTTTAATTCCTCAGTA-3')
to confirm the rsbV deletion. The nucleotide sequences of
the PCR fragments were determined with corresponding primers to confirm
the genetic construct which resulted from the insertion of
ermC into the respective genes within the sigB
operon. As an additional confirmation, chromosomal DNAs from the parent
strain FDA486 and the mutant strains
rsbU::ermC and
rsbV::ermC were digested with
EcoRV and probed in Southern hybridization experiments with
a PCR fragment (using primers 5'-GCTGGAATTCCGCCTGGATATATTTATC-3' and 5'-TTCCCCCGGGACTTATTAAAAATATTTATC-3') within the
rsbU gene or a PCR fragment (using primers
5'-TAAACTGCAGGAGCAGGTGCGAAATAAT-3' and
5'-GTGCAAGCTTTAATTCAGCGGTTAGTTC-3') within the
sigB gene.
Preparation of cell extracts and immunoblot analysis for
B protein.
Cell extracts were prepared from strains
FDA486 and RN6390 and their corresponding rsbU and
rsbV isogenic mutants. After pelleting, the cells were
resuspended in 1 ml of buffer (100 mM Tris-HCl [pH 7.5], 100 mM KCl,
5 mM EDTA, and 1 mM dithiothreitol) for lysostaphin treatment as
described previously (11). Protein samples (50 µg each)
were run in a sodium dodecyl sulfate-polyacrylamide gel electrophoresis
gel and then immunoblotted onto a nitrocellulose membrane. The membrane
was blocked with 2% bovine serum albumin at room temperature for
2 h. Anti-SigB monoclonal antibody 1D1 (8) was used
for the detection of
B (1:5,000 dilution) at
room temperature for 3 h, followed by another hour of incubation
with a 1:5,000 dilution of goat anti-mouse antibody conjugated to
alkaline phosphatase (Jackson ImmunoResearch, West Grove, Pa.).
Reactive bands were detected with developing substrates as described
previously (5).
Total RNA preparation. S. aureus strain FDA486 and its corresponding mutants were cultivated in Luria-Bertani (LB) broth to mid-log phase (optical density at 650 nm [OD650], 0.7), late log phase (OD650, 1.2), and post-exponential phase (OD650, 1.7). The cells were pelleted and resuspended in 1 ml of Trizol (Gibco-BRL, Gaithersburg, Md.) in combination with 0.1-mm-diameter zirconia-silica beads in a Fast Prep reciprocating shaker (Bio 101, Inc., San Diego, Calif.) as described previously (9). Total RNAs for reverse transcription (RT)-PCR required an additional DNase I treatment step. In brief, 50 µg of the RNA samples was incubated with RNase-free DNase I (1 U of RNA/µg) (Boehringer Mannheim, Indianapolis, Ind.) in 50 µl of buffer (50 mM Tris [pH 8.2], 5 mM Mg2SO4) for 30 min at 25°C. After phenol-chloroform extraction, RNA was precipitated with 2-propanol and resuspended in diethyl pyrocarbonate-treated water.
Two-step real-time quantitative PCR.
Total cellular RNAs,
isolated from the wild-type strain and the constructed mutants, were
reverse transcribed to cDNA using the TaqMan Reverse Transcription kit
(PE Applied Biosystems, Foster City, Calif.). PCRs were set up using
SYBR Green PCR Master mix (PE Applied Biosytems) according to the
manufacturer's instructions. Real-time detection and relative
quantitation were achieved with the ABI-PE Sequence Detection system
7700. We analyzed the two major transcripts produced from the
sigB operon. The
A-dependent
transcript was detected by PCR using a forward primer (5'-ATGGTTGGTTTAATAGGTGCC-3') and a reverse primer
(5'-ATACGTCGGAACATGTACA-3'), resulting in a 150-bp fragment
that corresponded to a region inside the rsbU gene.
Additional primers (5'-AAGTGATTCGTAAGGACGTCT-3' and
5'-TCGATAACTATAACCAAAGCCT-3') were designed to amplify a
fragment of the cDNA representing sigB, which is
encoded by the last gene in the operon, essentially encompassing both
the
A- and
B-dependent transcripts since these
transcripts overlap at the 3' end. As an endogenous control, forward
(5'-TTAGGTGCTGGGCAAATACA-3') and reverse
(5'-TGCATAACCAGCTAATGCTTC-3') primers were used to amplify a
150-bp fragment of the DNA gyrase gene. The calibrator in our study was
the
A-dependent transcript of the
sigB operon from the parental strain. The
CT value, representing the difference
in threshold cycle between the target and control genes, was determined
by subtracting the CT value of DNA gyrase
cDNA from the CT values for cDNA derived from the
A- and
B-dependent transcripts of the sigB
operon. The 
CT value was derived
from the subtraction of the resultant
CT values from the
CT value of the calibrator
(
A-dependent transcript).
2

CT was expressed as the
n-fold difference relative to the calibrator.
Northern blot hybridization.
Twenty micrograms of total
cellular RNA from FDA486 and its isogenic mutants was electrophoresed
through a 1.5% agarose-0.66 M formaldehyde gel in running buffer (20 mM morpholinepropanesulfonic acid [MOPS], 10 mM sodium acetate, 2 mM
EDTA, pH 7.0). Blotting of RNA onto Hybond N+
membranes (Amersham, Arlington Heights, Ill.) was performed with a Turbo-blotter alkaline transfer system (Scheicher & Schuell, Inc.,
Keene, N.H.). A gel-purified DNA probe of the sarA gene (2) was radiolabeled with
[
-32P]dCTP by the random primer method
(Ready-To-Go labeling kit; Pharmacia) and used to detect the
B-dependent sarA P3 transcript. The
blot was hybridized under high-stringency conditions, washed, and autoradiographed.
Assay for alpha-hemolysin. S. aureus strain FDA486 and the constructed mutants were tested for alpha-hemolysin production on sheep blood agar. Ten microliters of bacterial cultures harvested during the exponential phase (OD650, 0.5) was added to sheep blood agar, and the plate was incubated overnight at 37°C. The diameters of the clearing zones formed were compared between strains. In addition, alpha-hemolysin was also assayed by the microtiter method with rabbit erythrocytes. Briefly, the supernatants of overnight cultures were serially diluted in phosphate-buffered saline and incubated at 37°C for 2 h with 4% rabbit erythrocytes in a 96-well microtiter plate. Sodium dodecyl sulfate (1%) was used as a positive lysis control, and phosphate-buffered saline was used as a negative control. The plate was then read at 480 nm in a microtiter plate reader. Units of activity are expressed as the reciprocals of the dilutions giving 50% lysis.
Assay for sarA P3 activity in response to low
pH.
To monitor the sarA P3 promoter activity in
response to low pH, we used gfpuvr
as the reporter gene downstream of the sarA P3
promoter in shuttle plasmid pSK236. Experimentally, we introduced the
plasmid pALC1421 (pSK236 containing gfpuvr
preceded by a 162-bp sarA P3 promoter fragment; Table 1) by
electroporation into FDA486. We also assayed for sarA P3
promoter activity in response to acid stress. FDA486 and its isogenic
mutants
rsbU::ermC and
rsbV::ermC with pALC1421 were
inoculated into LB medium buffered to pH 7.0 or 5.5 with HCl, and the
bacterial cultures were grown with shaking at 37°C. Samples taken at
different time points of the growth cycle were analyzed in an FL600
microplate fluorescence reader (Bio-Tek Instruments, Winooski, Vt.)
with 485- to 516-nm filters. The pH changes were monitored in the
culture during the growth. Fluorescence values were expressed as total
fluorescence/OD650 to minimize small variations
in fluorescence due to cell densities. Percent differences of
sarA P3 activity caused by the low pH were calculated using
the following formula: [(fluorescence at pH 5.5/fluorescence at pH
7.5)
1.0] × 100.
Pigmentation test.
S. aureus strain
FDA486 and its isogenic mutants were analyzed for pigment formation.
One single colony of each strain was streaked onto an O3GL agar plate,
and the plate was incubated at 37°C for 24 to 36 h. To determine
the effect of RsbW on pigment production, a sigB-dependent
phenotype, we analyzed the pigment in strain FDA486 by overexpressing
RsbW. For overexpression, we used a tetracycline-inducible system
recently developed (unpublished data) to modulate the expression of
RsbW and, based upon the model of RsbW binding to
B in B. subtilis and
S. aureus (4, 13, 27), to detect the resultant
B activity attributable to the free
form of
B. Experimentally, the rsbW
gene was amplified from staphylococcal chromosomal DNA by PCR (using
primers
5'-AGCGTCGACAGGAGGTTATAAACATGCAATCTAAAGAAAATTTTA-3' and 5'-CTGCAGTTAGCTGATTTCGACTCTTC-3' [the sequence
containing the ribosome binding site is underlined]). The PCR
product was cloned into E. coli vector
pCR2.1-TOPO (Invitrogen) and subsequently introduced into the
tetracycline-inducible plasmid pALC2073 as an EcoRI
fragment. The resulting plasmid was designated pALC2197 (Table 1). The
orientation of the insert was verified by restriction mapping. The
recombinant plasmid was introduced into S. aureus strain RN4220 prior to transformation into strain FDA486. After confirmation with restriction mapping, a selected transformant of
FDA486 was streaked onto O3GL agar plates containing tetracycline (0, 80, and 200 ng/ml).
| |
RESULTS |
|---|
|
|
|---|
Construction of deletion mutants of rsbU and
rsbV.
Evidence is accumulating that RsbU has an
important role in activating
B in
S. aureus (16, 21). However, a
recent report from our laboratory revealed that an S. aureus strain with a natural rsbU deletion
(RN6390) can produce the SigB protein and activate transcription from
the
B-dependent sarA P3 promoter
(8). These data suggested that
B
can be activated by additional factors, independent of RsbU. To address
this question, we created deletions in the rsbU and rsbV genes (Fig. 1A) to
evaluate the resultant
B activity. PCR and
sequence analysis using oligonucleotides within the ermC
gene in combination with primers corresponding to regions downstream of
the respective cloned fragments showed that we had correctly inserted
ermC into the corresponding chromosomal regions within the
sigB operon. Southern hybridization experiments, using probes corresponding to the rsbU and sigB genes,
showed that the insertions had occurred correctly in the genetic
constructs (Fig. 1). Neither the downstream ribosome binding sites nor
the two promoters (
A and
B) of the sigB operon were affected
by the deletions.
|
Reduced expression of the
B protein in deletion
mutants.
Studies of B. subtilis have shown
that RsbU- or RsbP-dependent activation of
B
requires an intact rsbV allele (35). However,
the gene encoding RsbP is absent in S. aureus. We
blasted the amino acid sequence of the
B
regulation protein phosphatase, RsbP, against the staphylococcus N315
complete genome (available at http://www.ncbi.nlm.nih.gov). The best
hits seemed to be the phosphatase RsbU (E value = 4e
06) and a hypothetical protein with no
significant similarity to RsbP (E value = 0.033). To
assess whether mutations of the coding regions of the rsbU
and rsbV genes affected the expression of the
B protein differentially, we probed an
immunoblot of cell extracts of overnight cultures of the respective
mutants with an anti-
B monoclonal antibody.
Interestingly, inactivation of rsbU or rsbV did
not cause a complete abolition of
B protein
expression. As shown in Fig. 2, the
B protein levels in these two mutants were
lower than those in their parental counterparts. However, the
B expression was lower in the rsbV
mutant than it was in the rsbU mutant. We interpreted this
result with the idea that another factor, independent of RsbU, is
required to activate RsbV, since the rsbV mutant had lower
B protein expression than the rsbU
mutant. The expression of sigB, the last gene in the operon,
in both the rsbU and rsbV mutants is consistent
with the notion that the polar effect on sigB as a result of
the rsbU and rsbV mutations is likely to be
minimal. Additionally, the
A- and
B-dependent transcripts encoded within the
sigB operon were detectable in these mutants by real-time
RT-PCR with primers corresponding to the sigB gene, thus
confirming the relative integrity of both transcripts (see below).
|
Reduced
B-dependent transcription of the
sigB operon in the mutants.
Studies of
B. subtilis have demonstrated that the
B protein activates a
B-dependent promoter upstream of the
rsbV gene in the sigB operon. To examine whether
mRNA transcripts from the sigB operon were altered in the
rsbU and rsbV mutants, we performed real-time
RT-PCR analysis of total cellular RNA to detect
A- and
B-dependent
transcripts of the sigB operon during the post-exponential phase, a time at which
B activity is normally
at its highest. Using primers for the rsbU gene, we measured
the amount of the
A transcript since the
A-dependent promoter is found upstream of the
rsbU gene; with primers for the sigB gene, we
could detect a combination of the
A- and
B-dependent transcripts. The difference
between these two transcripts yielded the amount of the
B-dependent transcript. As shown in Fig.
3, the highest level of the
B-dependent transcript was found in the
parental strain and the lowest level was found in the rsbV
mutant. The amount of the
B-dependent
transcript in parental strain FDA486 was 28-fold higher than in the
corresponding
A-dependent transcript during
the post-exponential phase. Remarkably, the level of the
A-dependent transcript was similar between the
rsbU and rsbV mutants. However, the
B-dependent transcript decreased by more than
50% with an rsbU mutation and by more than 90% with an
rsbV mutation than it was in the parental control. Notably,
the
B-dependent transcript in the
rsbV mutant decreased to the level of the
A-dependent transcript within the same strain;
this contrasts with the parental strain, in which the
B-dependent transcript was much higher than
its
A counterpart. The finding that the
B transcript continued to be detected in the
rsbU and rsbV mutants implied that deletions of
these genes in our study did not disrupt the sigB
transcript. As a sigB primer was used to detect the
B-dependent transcript by RT-PCR, these data
also indicated that the sigB transcript was not truncated in
these mutants.
|
Reduction of the
B-dependent sarA P3
transcript in rsbU and rsbV deletion
mutants.
In previous studies, it has been reported that the
sarA P3 promoter is recognized by
B
and the sequence of this promoter shows strong homology to
B-dependent promoters described for
B. subtilis (12, 26, 27). In our
study, we showed by Northern analysis that the level of the
sarA P3 transcript was decreased in the rsbU and
rsbV mutants (Fig. 4) but not
absent, as found in the sigB mutant (data not shown). As
expected with a
B-dependent promoter, the
level of the sarA P3 transcript in FDA486 increased from the
mid-log (OD650, 0.7) to post-exponential
(OD650, 1.7) phases. A mutation in
rsbU resulted in a dramatic reduction in sarA P3
transcription, but the diminution of this transcript was even higher in
an rsbV mutant. Notably, the P3 transcript in the
rsbV mutant was not discernible until the cells reached the
post-exponential phase (OD650, 1.7). Based on our
data, we theorize that RsbU alone cannot account for the total
sarA P3 promoter activity via
B,
thus suggesting that an additional factor(s), possibly acting upon the
promoter upstream of rsbV or acting directly on the RsbV protein, may be involved.
|
Reduced pigmentation in the mutants.
In previous studies, it
was reported that a sigB deletion reduced pigment production
in S. aureus (21, 28). In addition, a
B-dependent promoter has been found in the
operon containing genes that encode the enzymes involved in the
carotenoid synthesis, CrtM and CrtN (42). We compared the
pigment production of FDA486 with that of the rsbU and
rsbV mutants to ascertain whether pigment synthesis
correlates with
B activity. Upon analyzing
these two strains on O3GL agar plates after 24 h of incubation at
37°C, an intense yellow pigment was observed in the wild-type strain,
whereas the pigments were reduced in the rsbU and
rsbV mutants (Fig. 5A).
|
Increased alpha-hemolysin activity in the mutants.
In previous
studies, it was reported that a sigB deletion could lead to
hyperproduction of alpha-hemolysin in S. aureus
(8). With FDA486 and its corresponding mutants, we could
also observe an increased zone of alpha-hemolysis in the mutants
compared to the wild-type strain. The diameters of the zone of
alpha-hemolysis surrounding colonies of isogenic mutants were bigger
than those of the parental strain (Table
2). This result was corroborated by
quantitative assays in microtiter wells in which the hemolytic titers
of the supernatants of the mutant and parental strains were compared.
The alpha-hemolytic titer was lowest for the parental strain and
highest for the rsbV mutant (Table 2), as one would predict
from the reduced
B activity in this mutant.
|
Induction of sarA P3 activity can be mediated by low
pH.
To assess whether
B activity could be
induced upon exposure to low pH, we measured
GFPuvr activity driven by the
sarA P3 promoter in media at pH 7.5 or 5.5. Our results
indicated that the activity of this promoter was significantly enhanced
when the culture was grown at pH 5.5 compared with identical medium
calibrated to pH 7.5 (Fig. 6). This
phenomenon was clearly much stronger in the wild-type strain than in
the two mutants. The sarA P3 activity increased more than
60% in the parental strain with the lower pH, whereas promoter
activity only increased 15 to 20% in the rsbU and
rsbV mutants in response to a low pH. These data imply that
activation of
B by acid stress is likely to be
mainly an RsbU-dependent phenomenon. In measuring the pH of the
bacterial culture during growth, we confirmed that the culture's pH
was almost constant during the sampling duration (data not shown).
|
Reduced
B activity with induction of RsbW.
Based upon previous data (4, 13, 27), it has been
speculated that RsbW may have sequestered SigB to modulate free
B activity in S. aureus.
To confirm this interaction, we used a tetracycline-inducible system to
modulate RsbW expression with various doses of tetracycline. The
effects of increasing RsbW induction with tetracycline on bacterial
pigment are illustrated in Fig. 5B. With the assumption that pigment
production responds positively to varying levels of free
B protein, the gradual induction of RsbW,
concomitant with the steady loss of pigment production in the induced
strain, supported previous reports that the expression of RsbW could
sequester free
B and, hence, block its
activity. The reduced binding of
B to the
B-dependent promoter of the staphyloxanthin
biosynthesis operon will thus diminish the ability of the induced
strain to produce pigment.
| |
DISCUSSION |
|---|
|
|
|---|
Comprehensive studies previously reported have elucidated the
mechanism of
B regulation in B. subtilis (1, 3, 4, 14, 18, 20, 33, 34, 35, 36, 37, 38,
39, 43). Contrary to that observed for S. aureus, activation of
B in
B. subtilis is complex, requiring a cascade of
events for the release of free
B from the
B-RsbW complex. Importantly, the activity of
B in B. subtilis is
dependent on the phosphorylation status of RsbV, controlled primarily
by two separate phosphatases, RsbU and RsbP (36, 37, 43).
The effect of rsbU, a gene lying upstream of
rsbV, on
B activity was also
reported by Wise and Price (43) and further substantiated
by Voelker et al. (37). In the case of S. aureus, recent studies have shown that a lack of RsbU resulted in
dramatic changes in
B activity compared to an
rsbU+ strain (16). As the
existence of an RsbP homolog was not confirmed in the recently released
S. aureus genome
(http://www.ncbi.nlm.nih.gov), activation of
B by a second pathway independent of RsbU in
S. aureus is not clearly defined.
In this study, we addressed this question by investigating the effect
of rsbU or rsbV mutation on the

protein level and its activity. We used
two different approaches to evaluate the level of
B activity. In our first approach, we measured
the extent of sigB transcription and translation. Using
quantitative real-time RT-PCR analyses with oligonucleotides
corresponding to sigB (i.e., combined
A- and
B-dependent
transcripts) and comparing them to those corresponding to
rsbU (i.e., a
A-dependent
transcript), we discovered that the level of
B-dependent transcripts was highest in the
parental strain FDA486 and lowest in the rsbV mutant.
Importantly, the
B-dependent transcript level
of the parental strain was much higher than that of the
A-dependent transcript during the
post-exponential phase. Additionally, the
B
transcript continued to be transcribed despite mutations in
rsbU and rsbV, indicating that the polar effect
on downstream genes was likely to be minimal. More specifically, the
B-dependent transcript decreased by more than
50% in the rsbU mutant and by greater than 90% in the
rsbV mutant than it did in the parental strain, thus
indicating the additional control in
B
activity via RsbV (Fig. 3). Immunoblot analysis disclosed that the
wild-type strain produced the greatest amounts of the
B protein while the
B
protein level in the rsbU mutant was lower but still higher
than that in the rsbV mutant. The amounts of the
B protein correlated quite well with the
levels of the sigB transcript. Collectively, these data
imply that the expression of SigB during the post-exponential phase is
largely controlled by the
B-dependent promoter
upstream of rsbV.
In our second approach, we determined
B
activity by measuring transcription from the sarA P3
promoter. Studies by Deora et al. (12) and Bishai et al.
(27) as well as from our lab (8, 26) have
shown that the sarA P3 promoter of S. aureus is a
B-dependent promoter.
Northern blot analysis with a sarA probe revealed that the
level of the P3 transcript was dramatically reduced in the isogenic
mutants compared to that of FDA486. In particular, the rsbV
mutant has a lower level of P3 transcription than that of the
RsbU mutant (Fig. 4). In addition, the markedly reduced
transcription from the sarA P3 promoter in the isogenic mutants correlated well with reductions in
B
protein levels and transcription from the
B-dependent promoter upstream of
rsbV (Fig. 2 and 3). Taken together, and applying the
working model of B. subtilis (38),
there appear to be at least two pathways for
B
activation in S. aureus, one which is
dependent on RsbU and another which is independent of RsbU but
dependent on RsbV.
We also investigated two functions, pigment and alpha-hemolysin
production, phenotypes that are controlled directly (pigment) or
indirectly (alpha-hemolysin) by
B. The
positive influence of
B on staphylococcal
pigmentation was originally reported by Kullik et al. (21)
and recently substantiated by Giachino et.al. (16). In our
study, we also observed a progressive loss of pigment production from
parent to rsbU and rsbV mutants (Fig. 5). This
finding, coupled with those of the
B protein
level (Fig. 2) and their associated activities (Fig. 4), clearly
implied a correlation in
B levels and the
degree of pigment production. Previous work from our laboratory
demonstrated that the production of alpha-hemolysin is negatively
controlled by
B (8), probably
indirectly controlled by regulating transcription from the
sarA P3 promoter. A reduction in P3 activity as a result of
declining
B expression or activity leads to
increased expression of SarA which, in turn, modulates the
alpha-hemolysin gene via an SarA-dependent pathway (8).
Taking advantage of the cytolytic effects of alpha-hemolysin upon
rabbit erythrocytes, we performed two functional assays for alpha-hemolysin production, with both disclosing increased hemolytic activity in the rsbU and rsbV mutants compared
with the parental strain. The hemolytic activity appeared to be higher
for the rsbV mutant than for the rsbU mutant,
hence confirming the negative impact of
B
activity on alpha-hemolysin expression.
Finally, we found that the
B activity
responded positively to acid stress and that the staphylococcal pigment
could be negatively controlled by different levels of the RsbW protein.
The response to acid stress was strongest in the wild-type strain, with
sarA P3 activity increased by more than 60%, whereas the
analogous response in the two mutants resulted in a 15 to 20% increase
in activity. Thus, the activation of
B in
response to acid stress is dependent mainly on RsbU. However, we did
not rule out the possibility that RsbV may mediate
B activation in response to other
environmental stresses (e.g., antibiotic or drug stress). We also
analyzed the pigment of FDA486 in response to different levels of RsbW
provided under inducible conditions. With the idea that RsbW may
function as an anti-
factor (4, 13, 27), we modulated
rsbW expression using a tetracycline-inducible system and
analyzed the pigment as an indication of free
B activity. Our data clearly confirmed the
ability of RsbW to sequester
B to block its
free-form activity. More specifically, colonies of the wild-type strain
produced a strong yellow or orange pigment in the absence of
tetracycline while the pigment was completely lost in 200 ng of
tetracycline/ml, a concentration that has been shown to significantly
induce RsbW expression.
In conclusion, this study ascertained that the expression and activity
of
B protein are only partially dependent on
RsbU during bacterial growth, indicating that additional factors are
required for full
B activity in S. aureus. Based on our data, we propose an additional but
complementary model of
B regulation involving
an RsbU-independent pathway to convert RsbV-P to RsbV.
| |
ACKNOWLEDGMENTS |
|---|
This work was partially supported by NIH grant AI37142. We thank the Office of International Affairs at Karolinska Institutet for fellowship support.
We thank TIGR and the University of Oklahoma Genome Center for access to the staphylococcal genome. Willem Van Wamel is acknowledged for fruitful discussions and comments.
| |
FOOTNOTES |
|---|
* Corresponding author. Mailing address: Department of Microbiology, Dartmouth Medical School, Vail 206, Hanover, NH 03755. Phone: (603) 650-1310. Fax: (603) 650-1362. E-mail: Ambrose.Cheung{at}Dartmouth.EDU.
Editor: E. I. Tuomanen
| |
REFERENCES |
|---|
|
|
|---|
| 1. | Akbar, S., C. M. Kang, T. A. Gaidenko, and C. W. Price. 1997. Modulator protein RsbR regulates environmental signalling in the general stress pathway of Bacillus subtilis. Mol. Microbiol. 24:567-578[CrossRef][Medline]. |
| 2. |
Bayer, M. G.,
J. H. Heinrichs, and A. L. Cheung.
1996.
The molecular architecture of the sar locus in Staphylococcus aureus.
J. Bacteriol.
178:4563-4570 |
| 3. |
Benson, A. K., and W. G. Haldenwang.
1992.
Characterization of a regulatory network that controls B expression in Bacillus subtilis.
J. Bacteriol.
174:749-757 |
| 4. |
Benson, A. K., and W. G. Haldenwang.
1993.
Bacillus subtilis B is regulated by a binding protein (RsbW) that blocks its association with core RNA polymerase.
Proc. Natl. Acad. Sci. USA
90:2330-2334 |
| 5. | Blake, M. S., K. H. Johnston, G. J. Russell-Jones, and E. C. Gotschlich. 1984. A rapid sensitive method for detection of alkaline phosphatase-conjugated anti-antibody on Western blots. Anal. Biochem. 136:175-179[CrossRef][Medline]. |
| 6. | Bodén, M., and J.-I. Flock. 1994. Cloning and characterization of a gene for a 19 kDa fibrinogen binding protein from Staphylococcus aureus. Mol. Microbiol. 12:599-606[CrossRef][Medline]. |
| 7. |
Chan, P. F.,
S. J. Foster,
E. Ingham, and M. O. Clements.
1998.
The Staphylococcus aureus alternative sigma factor B controls the environmental stress response but not starvation survival or pathogenicity in a mouse abscess model.
J. Bacteriol.
180:6082-6089 |
| 8. |
Cheung, A. L.,
Y.-T. Chien, and A. S. Bayer.
1999.
Hyperproduction of alpha-hemolysin in a sigB mutant is associated with elevated SarA expression in Staphylococcus aureus.
Infect. Immun.
67:1331-1337 |
| 9. | Cheung, A. L., K. Eberhardt, and V. A. Fischetti. 1994. A method to isolate RNA from gram-positive bacteria and mycobacteria. Anal. Biochem. 222:511-514[CrossRef][Medline]. |
| 10. |
Cheung, A. L.,
C. C. Nast, and A. S. Bayer.
1998.
Selective activation of sar promoters with the use of green fluorescent protein transcriptional fusions as the detection system in the rabbit endocarditis model.
Infect. Immun.
66:5988-5993 |
| 11. |
Chien, Y.-T., and A. L. Cheung.
1998.
Molecular interactions between two global regulators, sar and agr, in Staphylococcus aureus.
J. Biol. Chem.
273:2645-2652 |
| 12. |
Deora, R.,
T. Tseng, and T. K. Misra.
1997.
Alternative transcription factor SB of Staphylococcus aureus: characterization and role in transcription of the global regulatory locus sar.
J. Bacteriol.
179:6355-6359 |
| 13. |
Dufour, A., and W. G. Haldenwang.
1994.
Interactions between a Bacillus subtilis anti-sigma factor (RsbW) and its antagonist (RsbV).
J. Bacteriol.
176:1813-1820 |
| 14. |
Dufour, A.,
U. Voelker,
A. Voelker, and W. G. Haldenwang.
1996.
Relative levels and fractionation properties of Bacillus subtilis B and its regulators during balanced growth and stress.
J. Bacteriol.
178:3701-3709 |
| 15. |
Gaidenko, T. A., and C. W. Price.
1998.
General stress transcription factor B and sporulation transcription factor H each contribute to survival of Bacillus subtilis under extreme growth conditions.
J. Bacteriol.
180:3730-3733 |
| 16. |
Giachino, P.,
S. Engelmann, and M. Bischoff.
2001.
B activity depends on RsbU in Staphylococcus aureus.
J. Bacteriol.
183:1843-1852 |
| 17. | Gross, C. A., M. Lonetto, and R. Losick. 1992. Bacterial sigma factors, p. 129-176. In K. Yamamoto, and S. McKnight (ed.), Transcriptional regulation. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y. |
| 18. |
Haldenwang, W. G.
1995.
The sigma factors of Bacillus subtilis.
Microbiol. Rev.
59:1-30 |
| 19. | Helmann, J. D., and M. J. Chamberlin. 1988. Structure and function of bacterial sigma factors. Annu. Rev. Biochem. 57:839-872[CrossRef][Medline]. |
| 20. |
Kalman, S.,
M. L. Duncan,
S. M. Thomas, and C. W. Price.
1990.
Similar organization of the sigB and spoIIA operons encoding alternative sigma factors of Bacillus subtilis RNA polymerase.
J. Bacteriol.
172:5575-5585 |
| 21. |
Kullik, I.,
P. Giachino, and T. Fuchs.
1998.
Deletion of the alternative sigma factor B in Staphylococcus aureus reveals its function as a global regulator of virulence genes.
J. Bacteriol.
180:4814-4820 |
| 22. |
Kullik, I., and P. Giachino.
1997.
The alternative sigma factor B in Staphylococcus aureus: regulation of the sigB operon in response to growth phase and heat shock.
Arch. Microbiol.
167:151-159[CrossRef][Medline].
|
| 23. | Lee, C. Y. 1992. Cloning of genes affecting capsule expression in Staphylococcus aureus strain M. Mol. Microbiol. 6:1515-1522[Medline]. |
| 24. |
Lonetto, M.,
M. Gribskov, and C. A. Gross.
1992.
The 70 family: sequence conservation and evolutionary relationships.
J. Bacteriol.
174:3843-3849 |
| 25. |
Lonetto, M. A.,
K. L. Brown,
K. E. Rudd, and M. J. Buttner.
1994.
Analysis of the Streptomyces coelicolor sigE gene reveals the existence of a subfamily of eubacterial RNA polymerase factors involved in the regulation of extracytoplasmic functions.
Proc. Natl. Acad. Sci. USA
91:7573-7577 |
| 26. |
Manna, A. C.,
M. G. Bayer, and A. L. Cheung.
1998.
Transcriptional analysis of different promoters in the sar locus in Staphylococcus aureus.
J. Bacteriol.
180:3828-3836 |
| 27. |
Miyazaki, E.,
J.-M. Chen,
C. Ko, and W. R. Bishai.
1999.
The Staphylococcus aureus rsbW (orf159) gene encodes an anti-sigma factor of SigB.
J. Bacteriol.
181:2846-2851 |
| 28. |
Nicholas, R. O.,
T. Li,
D. McDevitt,
A. Marra,
S. Sucoloski,
P. L. Demarsh, and D. R. Gentry.
1999.
Isolation and characterization of a sigB deletion mutant of Staphylococcus aureus.
Infect. Immun.
67:3667-3669 |
| 29. | Novick, R. 1991. Genetic systems in staphylococci. Methods Enzymol. 204:587-636[Medline]. |
| 30. | Novick, R. P. 1990. The staphylococcus as a molecular genetic system, p. 1-40. In R. P. Novick (ed.), Molecular biology of staphylococci. VCH Publishers, New York, N.Y. |
| 31. | Palma, M., S. Nozohoor, T. Schennings, A. Heimdahl, and J. Flock. 1996. Lack of the extracellular 19-kilodalton fibrinogen-binding protein from Staphylococcus aureus decreases virulence in experimental wound infection. Infect. Immun. 64:5284-5289[Abstract]. |
| 32. |
Rachid, S.,
K. Ohlsen,
U. Wallner,
J. Hacker,
M. Hecker, and W. Ziebuhr.
2000.
Alternative transcription factor B is involved in regulation of biofilm expression in a Staphylococcus aureus mucosal isolate.
J. Bacteriol.
182:6824-6826 |
| 33. |
Scott, J. M., and W. G. Haldenwang.
1999.
Obg, an essential GTP binding protein of Bacillus subtilis, is necessary for stress activation of transcription factor B.
J. Bacteriol.
181:4653-4660 |
| 34. |
Scott, J. M.,
J. Ju,
T. Mitchell, and W. G. Haldenwang.
2000.
The Bacillus subtilis GTP binding protein Obg and regulators of the B stress response transcription factor cofractionate with ribosomes.
J. Bacteriol.
182:2771-2777 |
| 35. |
Smirnova, N.,
J. Scott,
U. Voelker, and W. G. Haldenwang.
1998.
Isolation and characterization of Bacillus subtilis sigB operon mutations that suppress the loss of the negative regulator RsbX.
J. Bacteriol.
180:3671-3680 |
| 36. |
Vijay, M.,
M. S. Brody,
E. Fredlund, and C. W. Price.
2000.
A PP2C phosphatase containing a PAS domain is required to convey signals of energy stress to the B transcription factor of Bacillus subtilis.
Mol. Microbiol.
35:180-188[CrossRef][Medline].
|
| 37. |
Voelker, U.,
A. Dufour, and W. G. Haldenwang.
1995.
The Bacillus subtilis rsbU gene product is necessary for RsbX-dependent regulation of B.
J. Bacteriol.
177:114-122 |
| 38. |
Voelker, U.,
A. Voelker,
B. Maul,
M. Hecker,
A. Dufour, and W. Haldenwang.
1995.
Separate mechanisms activate B of Bacillus subtilis in response to environmental and metabolic stresses.
J. Bacteriol.
177:3771-3780 |
| 39. |
Voelker, U.,
T. Luo,
N. Smirnova, and W. G. Haldenwang.
1997.
Stress activation of Bacillus subtilis B can occur in the absence of the B negative regulator RsbX.
J. Bacteriol.
179:1980-1984 |
| 40. |
Voelker, U.,
B. Maul, and M. Hecker.
1999.
Expression of the B-dependent general stress regulon confers multiple stress resistance in Bacillus subtilis.
J. Bacteriol.
181:3942-3948 |
| 41. | Welsh, K. M., K. A. Trach, C. Folger, and J. A. Hoch. 1994. Biochemical characterization of the essential GTP-binding protein Obg of Bacillus subtilis. 176:7161-7168. |
| 42. |
Wieland, B.,
C. Feil,
E. Gloria-Maercker,
G. Thumm,
M. Lechner,
J.-M. Bravo,
K. Poralla, and F. Gotz.
1994.
Genetic and biochemical analysis of the biosynthesis of the yellow carotenoid 4,4'-diaponeurosporene of Staphylococcus aureus.
J. Bacteriol.
176:7719-7726 |
| 43. |
Wise, A. A., and C. W. Price.
1995.
Four additional genes in the sigB operon of Bacillus subtilis that control activity of the general stress factor B in response to environmental signals.
J. Bacteriol.
177:123-133 |
| 44. |
Wu, S.,
H. de Lencastre, and A. Tomasz.
1996.
Sigma-B, a putative operon encoding alternate sigma factor of Staphylococcus aureus RNA polymerase: molecular cloning and DNA sequencing.
J. Bacteriol.
178:6036-6042 |
This article has been cited by other articles: